Prediction of drug-induced liver injury in humans by using in vitro methods: the case of ximelagatran

Toxicology in Vitro : an International Journal Published in Association with BIBRA
Kerstin KenneTommy B Andersson

Abstract

To investigate the possible mechanisms underlying the liver enzyme elevations seen during clinical studies of long-term treatment (>35 days) with ximelagatran, and investigate the usefulness of pre-clinical in vitro systems to predict drug-induced liver effects. Ximelagatran and its metabolites were tested for effects on cell viability, mitochondrial function, formation of reactive metabolites and reactive oxygen species, protein binding, and induction of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) gene expression or nuclear orphan receptors. Experimental systems included fresh and cryopreserved hepatocytes, human hepatoma cell lines (HepG2 and HuH-7) and subcellular human liver fractions. Loss of cell viability was only seen in HepG2 cells at ximelagatran concentrations 100 microM and in cryopreserved human hepatocytes at 300 microM, while HuH-7 cells were not affected by 24 h exposure at up to 300 microM ximelagatran. Calcium homeostasis was not affected in HepG2 cells exposed to ximelagatran up to 300 microM for 15 min. There was no evidence for the formation of reactive metabolites when cell systems were exposed to ximelagatran. ALT and AST expression in human hepatoma cell lines were also unchanged ...Continue Reading

References

Sep 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E FréneauxD Pessayre
Jan 1, 1983·Methods in Enzymology·G L Peterson
Jun 19, 1998·Chemico-biological Interactions·P WolkensteinP Beaune
May 16, 2000·Cell Biology and Toxicology·D PessayreB Fromenty
Aug 1, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D HaouziD Pessayre
Oct 14, 2000·Annual Review of Cell and Developmental Biology·J J Repa, D J Mangelsdorf
Apr 3, 2001·Journal of Hepatology·S Krähenbühl
Feb 1, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Marita LarssonBengt-Arne Persson
Feb 14, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ulf G ErikssonDavid Gustafsson
Apr 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Bernd Clement, Katrin Lopian
May 14, 2003·Journal of the American College of Cardiology·Palle PetersenUNKNOWN SPORTIF II Investigators
May 14, 2003·European Journal of Clinical Pharmacology·Ulf G ErikssonDavid Gustafsson
Jul 23, 2003·Current Drug Metabolism·M J Gómez-LechónR Jover
Aug 2, 2003·The New England Journal of Medicine·William M Lee
Oct 31, 2003·The New England Journal of Medicine·Sam SchulmanUNKNOWN THRIVE III Investigators
Nov 12, 2003·Biochemical Pharmacology·M José Gómez-LechónRamiro Jover
Dec 17, 2003·Clinical Pharmacokinetics·Hongbing Wang, Edward L LeCluyse
Dec 31, 2003·Biochemical Pharmacology·Céline TomkiewiczMartine Aggerbeck
Feb 11, 2005·JAMA : the Journal of the American Medical Association·Jean-Noel FiessingerUNKNOWN THRIVE Treatment Study Investigators
Feb 11, 2005·JAMA : the Journal of the American Medical Association·Gregory W AlbersUNKNOWN SPORTIF Executive Steering Committee for the SPORTIF V Investigators
Mar 24, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·William M LeeSunita Sheth
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·B Kevin ParkDominic P Williams
Aug 27, 2005·Seminars in Vascular Medicine·Michael WolztUlf G Eriksson
Feb 17, 2006·The New England Journal of Medicine·Victor J Navarro, John R Senior
Dec 1, 2006·Apoptosis : an International Journal on Programmed Cell Death·Yoshihide Tsujimoto, Shigeomi Shimizu

❮ Previous
Next ❯

Citations

Apr 27, 2013·European Journal of Clinical Pharmacology·Sebastian Harder, Jochen Graff
Sep 19, 2008·Expert Opinion on Drug Metabolism & Toxicology·André Guillouzo, Christiane Guguen-Guillouzo
May 26, 2015·Expert Opinion on Drug Metabolism & Toxicology·Mark P Grillo
Sep 7, 2011·Drug Metabolism Reviews·Dominique PessayreAbdellah Mansouri
Feb 1, 2012·Expert Opinion on Drug Metabolism & Toxicology·David E Amacher
Dec 11, 2014·Expert Opinion on Drug Metabolism & Toxicology·Jane I Grove, Guruprasad P Aithal
Sep 29, 2009·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Ulf AnderssonIna Schuppe-Koistinen
Nov 15, 2013·Thérapie·Julie FulcrandUNKNOWN le réseau des Centres régionaux de Pharmacovigilance
Jun 26, 2010·Gastroentérologie Clinique Et Biologique·F Ballet
Jul 21, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Odile SergentDominique Lagadic-Gossmann
Jul 22, 2008·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Ylva EdlingMagnus Ingelman-Sundberg
Aug 2, 2008·Alimentary Pharmacology & Therapeutics·N K Gupta, J H Lewis
Nov 29, 2013·Journal of Labelled Compounds & Radiopharmaceuticals·Roger SimonssonCharles S Elmore
Feb 26, 2013·Journal of Clinical Pharmacology·Alberto Corsini, Michele Bortolini
Apr 6, 2016·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Marlies OortsLysiane Richert
Jul 4, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Evangelia LiakoniStephan Krähenbühl
Mar 10, 2015·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Laleh KamalianB Kevin Park
Jan 5, 2013·Toxicology·Xavier TekpliDominique Lagadic-Gossmann
Nov 27, 2014·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Gudrun OttBernd Clement
Jul 2, 2016·Toxicology Letters·Lysiane RichertDominic P Williams
Aug 20, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Matthew G BurbankAndré Guillouzo
Jun 2, 2010·Nature Reviews. Drug Discovery·Federico M GoodsaidIssam Zineh
Jan 16, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gudrun OttAntje Havemeyer
Jul 2, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gustav HolmgrenJosefina Edsbagge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
William M LeeSunita Sheth
International Journal of Technology Assessment in Health Care
Lisa KwokMichel Boucher
Toxicology in Vitro : an International Journal Published in Association with BIBRA
Ylva EdlingMagnus Ingelman-Sundberg
© 2021 Meta ULC. All rights reserved